Trial · NCT07879742
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 16 of 16
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in biological age (epigenetic age) | From baseline to end of intervention (1 year) | DunedinPACE epigenetic clock |
| Secondary | Change in biological age (epigenetic age) | From baseline to end of intervention (1 year) | GrimAge epigenetic clock |
| Secondary | Change in biological age (epigenetic age) | From baseline to end of intervention (1 year) | PhenoAge epigenetic clock |
| Secondary | Change in biological age (epigenetic age) | From baseline to end of intervention (1 year) | Horvath and Hannum epigenetic clock |
| Secondary | Change in biological age (epigenetic age) | From baseline to end of intervention (1 year) | SYMPHONYAge (SystemsAge of each organ system) |
| Secondary | Change in biological age (epigenetic age) | From baseline to end of intervention (1 year) | OMICm Age |
| Secondary | Change in biological age | From baseline to end of intervention (1 year) | Immune Cell Deconvolution |
| Secondary | Change in biological age | From baseline to end of intervention (1 year) | Telomere |
| Secondary | Change in biological age based on composite biomarker approach | From baseline to end of intervention (1 year) | Published algorithm derived from clinical blood chemistries |
| Secondary | Epigenome-wide association study (EWAS) | From baseline to end of intervention (1 year) | |
| Secondary | Change in quality of life (RAND-36) | From baseline to end of intervention (1 year) | RAND 36-Item Health Survey (RAND-36). Scores range from 0 to 100. Higher values mean a more favorable health state. |
| Secondary | Change in self-reported cognitive function | From baseline to end of intervention (1 year) | PROMIS Cognitive Function - Abilities-Short Form 8a. Raw scores range from 8 to 40. Raw Score will be converted to a standardized PROMIS T-score. Higher T-scores represent better cognitive function/abilities |
| Other | Change in blood inflammatory marker level | From baseline to end of intervention (1 year) | C Reactive Protein (hsCRP) |
| Other | Change in blood inflammatory marker level | From baseline to end of intervention (1 year) | Erythrocyte Sedimentation Rate (ESR) |
| Other | Change in blood inflammatory marker level | From baseline to end of intervention (1 year) | Interleukin 6 (IL 6) |
| Other | Change in blood oxidative marker level | From baseline to end of intervention (1 year) | Malondialdehyde (MDA) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07879742/registered